His primary areas of study are Microbiology, Drug resistance, Antibiotic resistance, Antimicrobial susceptibility and Biotechnology. Microbiology is closely attributed to Bacteria in his research. The Drug resistance study combines topics in areas such as Antibiotics, Fosfomycin, Ceftolozane, Plazomicin and Escherichia coli.
His work focuses on many connections between Antibiotic resistance and other disciplines, such as Public health, that overlap with his field of interest in Absolute number and Disease. Gunnar Kahlmeter has researched Antimicrobial susceptibility in several fields, including Clinical microbiology, Horse blood and Mueller-Hinton agar. Gunnar Kahlmeter interconnects Pseudomonas aeruginosa, Multiple drug resistance, Enterococcus and Acinetobacter in the investigation of issues within Antimicrobial.
His scientific interests lie mostly in Microbiology, Antimicrobial susceptibility, Antibiotic resistance, Antibiotics and Antimicrobial. His Microbiology research incorporates elements of Staphylococcus aureus, Agar and Escherichia coli. His Antimicrobial susceptibility study incorporates themes from Clostridium difficile, Broth microdilution, Biotechnology and Computational biology.
His Antibiotic resistance research incorporates elements of Infection control, Virology, Environmental health, Public health and Drug resistance. His Antimicrobial research is multidisciplinary, incorporating perspectives in Inhibition zone and Intensive care medicine. His Klebsiella pneumoniae research includes themes of Pseudomonas aeruginosa, Colistin and Acinetobacter.
Microbiology, Antimicrobial susceptibility, Internal medicine, Broth microdilution and Antimicrobial are his primary areas of study. The Microbiology study combines topics in areas such as Staphylococcus pseudintermedius, Mycobacterium tuberculosis complex, Methicillin resistance, Agar and Klebsiella pneumoniae. His study looks at the intersection of Mycobacterium tuberculosis complex and topics like Drug resistance with Antibiotic resistance.
His study in the fields of Retrospective cohort study under the domain of Internal medicine overlaps with other disciplines such as Safety studies. His Antimicrobial research is multidisciplinary, relying on both Test, Dosing regimen, Pharmacokinetics, Susceptibility testing and Drug. His studies deal with areas such as Pseudomonas aeruginosa and Acinetobacter as well as Agar plate.
His primary scientific interests are in Antimicrobial susceptibility, Microbiology, Antimicrobial, Internal medicine and Risk analysis. His Antimicrobial susceptibility study is concerned with the larger field of Antibiotic resistance. His Microbiology study typically links adjacent topics like Mycobacterium tuberculosis complex.
His Antimicrobial study combines topics from a wide range of disciplines, such as Pharmacokinetics, Therapeutic drug monitoring, Susceptibility testing and Intensive care medicine. Gunnar Kahlmeter has researched Internal medicine in several fields, including Amphotericin B, Itraconazole, Posaconazole, Colistin and Polymyxin. His Risk analysis study combines topics in areas such as Microbiological Techniques and Quality assurance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A-P Magiorakos;A Srinivasan;R B Carey;Y Carmeli.
Clinical Microbiology and Infection (2012)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli;Elena Carrara;Alessia Savoldi;Stephan Harbarth.
Lancet Infectious Diseases (2017)
The global threat of antimicrobial resistance: science for intervention
Ignasi Roca;Murat Akova;F. Baquero;Jean Carlet.
new microbes and new infections (2015)
EUCAST expert rules in antimicrobial susceptibility testing
R. Leclercq;R. Cantón;D.F.J. Brown;C.G. Giske.
Clinical Microbiology and Infection (2013)
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
E. Tacconelli;M.A. Cataldo;S.J. Dancer;G. De Angelis.
Clinical Microbiology and Infection (2014)
Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories
E. Matuschek;D.F.J. Brown;G. Kahlmeter.
Clinical Microbiology and Infection (2014)
Aminoglycoside toxicity – a review of clinical studies published between 1975 and 1982
Gunnar Kahlmeter;Jörgen I. Dahlager.
Journal of Antimicrobial Chemotherapy (1984)
European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria
Gunnar Kahlmeter;Derek F. J. Brown;Fred W. Goldstein;Alasdair P. MacGowan.
Journal of Antimicrobial Chemotherapy (2003)
Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use
Ingo Klare;Carola Konstabel;Guido Werner;Geert Huys.
Journal of Antimicrobial Chemotherapy (2007)
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values
J. Turnidge;G. Kahlmeter;G. Kronvall.
Clinical Microbiology and Infection (2006)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: